CD8A and melanoma: To explore how the dynamics of the CD8+ T cells changed in response to checkpoint blockade therapy, animals bearing B16 melanoma were treated with CTLA-4 blockade and then subjected to CD8-PET imaging longitudinally over the course of four treatments on days 9, 16, 23, and 30 following tumor inoculation.